Greedy Insider · Filing
VIR · 13D amendment · ARCH Venture Fund IX, L.P. and affiliates
ARCH Venture Fund IX, L.P. and affiliates reported a 7.3% stake in Vir Biotechnology, Inc. (VIR) in a Schedule 13D amendment filed on Nov 6, 2026, triggered by an event on Nov 4, 2026.
Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001012975-26-001020